5 Result(s)
-
Article
Open AccessDistinct changes to pancreatic volume rather than pancreatic autoantibody positivity: insights into immune checkpoint inhibitors induced diabetes mellitus
Immune checkpoint inhibitors (ICI) are promising treatment options for various cancers. However, their use is associated with immune-related adverse events (irAEs), including ICI-induced diabetes mellitus (ICI...
-
Chapter
Chemotherapy and Biochemotherapy for Melanoma
The incidence of melanoma is increasing around the world, with the majority of patients diagnosed with a localized disease. Surgical treatment remains the preferred treatment method for localized diseases. How...
-
Article
TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib
In this retrospective review of prospectively collected data, we sought to investigate whether early FDG-PET assessment of treatment response based on total lesion glycolysis measured using a systemic approach...
-
Article
Response to Sorafenib in a Patient with Metastatic Xp11 Translocation Renal Cell Carcinoma
Sorafenib, a multikinase inhibitor of tumour-cell proliferation and angiogenesis, has been shown to have a role in the treatment of metastatic renal cell carcinoma (RCC). Xp11 translocation carcinoma is a rare...
-
Article
Predictors for patterns of brain relapse and overall survival in patients with non-small cell lung cancer
Our goal was to investigate prognostic factors for different patterns of brain relapse and overall survival so that treatments could be tailored and treatment outcomes improved. We studied 292 patients with no...
